Blood Cultures's Profitability in Intensive Care Unit
Completed
- Conditions
- Bacteremia
- Registration Number
- NCT02869191
- Lead Sponsor
- Hospital Universitario Getafe
- Brief Summary
The purpose of this study is to assess the blood cultures' profitability in intensive care unit and create a validated prediction rule for extractioning in critical patients.
- Detailed Description
Implementing a predictive rule blood cultures to determine the probability of positive or negative result, improving the profitability of the diagnostic test.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 900
Inclusion Criteria
- Patients who have been extracted blood culture sample
Exclusion Criteria
- Under-aged, pregnants, Major burns.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of positive, negative and contaminated blood cultures 2 years
- Secondary Outcome Measures
Name Time Method Percentage of positive, negative and contaminated blood cultures after training program 9 months the effect of applying a blood culture extraction protocol is measured
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie bacteremia detection via blood cultures in ICU settings?
How does blood culture profitability in NCT02869191 compare to rapid diagnostic tests for sepsis?
Which biomarkers correlate with positive blood culture outcomes in critical care patients?
What adverse events are associated with overuse of blood cultures in ICU and how are they managed?
Are there alternative sepsis diagnostic approaches to blood cultures in ICU patient management?
Trial Locations
- Locations (1)
Hopsital Universitario de Getafe
🇪🇸Getafe, Madrid, Spain
Hopsital Universitario de Getafe🇪🇸Getafe, Madrid, Spain